Beijing Daxiang Biotech Co.
Latest round
- Series B
Last raised
- Feb 2026
Total raised
- $16M
Investors
- 9
About Beijing Daxiang Biotech Co.
, Ltd. operates as a biochip developer that provides Organ-on-a-Chip and Organoid. In August 2020, the company launched the first batch of domestic commercial organ chips., Ltd. became the strategic partner of the company., Ltd. provides organ chips, organoid for many fields, such as new drug development, disease modeling and individualized precision medicine. Its products are divided into in vitro models, microarray products, devices and kits. Microarray products include high-throughput barrier function organs-on-chips, organoid expansion chip for dynamic culture and high-throughput 3D microchip for organoid culture and drug screening. The company also provides drug discovery, clinical translation and basic research. The company generates revenue by doing research, development, sales of its products and providing other related services.
Who invested in Beijing Daxiang Biotech Co.
9 investors across 4 rounds
See all investors in Beijing Daxiang Biotech Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Beijing Daxiang Biotech Co.
Who invested in Beijing Daxiang Biotech Co.?
Beijing Daxiang Biotech Co. has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beijing Daxiang Biotech Co. raised?
Beijing Daxiang Biotech Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Beijing Daxiang Biotech Co. last raise money?
Beijing Daxiang Biotech Co.'s most recent round on record is a Series B, in Feb 2026.
What does Beijing Daxiang Biotech Co. do?
Beijing Daxiang Biotech Co. is a biotechnology company.
Where is Beijing Daxiang Biotech Co. headquartered?
Beijing Daxiang Biotech Co. is headquartered in Beijing, China.
Which VCs invest in companies like Beijing Daxiang Biotech Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Beijing Daxiang Biotech Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Beijing Daxiang Biotech Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.